{"output": [["Walgreens Boots Alliance Inc", "COMP", "Report", "sixth straight fall", "ECON_INDICATOR"], ["Walgreens Boots Alliance Inc", "COMP", "Operate_In", "Retail Pharmacy USA", "SECTOR"], ["Retail Pharmacy USA", "SECTOR", "Record", "biggest intraday percentage loss", "ECON_INDICATOR"], ["Retail Pharmacy USA", "SECTOR", "Hurt", "weak demand", "CONCEPT"], ["Retail Pharmacy USA", "SECTOR", "Comparable pharmacy sales", "7.4 percent", "ECON_INDICATOR"], ["Retail Pharmacy USA", "SECTOR", "Gross margins", "24.9 percent", "ECON_INDICATOR"], ["Retail Pharmacy USA", "SECTOR", "Add", "1,932 Rite Aid stores", "COMP"], ["Retail Pharmacy USA", "SECTOR", "Impact", "acquisition", "EVENT"], ["Retail Pharmacy USA", "SECTOR", "Raise", "doubts", "CONCEPT"], ["Retail Pharmacy USA", "SECTOR", "Perspective", "handful of years", "TIME"], ["Retail Pharmacy USA", "SECTOR", "Did not detail", "recent tax overhaul", "EVENT"], ["CVS Health Corp", "COMP", "Rise", "4 percent", "ECON_INDICATOR"], ["CVS Health Corp", "COMP", "Boost", "$1.2 billion", "MONEY"], ["CVS Health Corp", "COMP", "Operate_In", "Global Markets", "SECTOR"], ["Walgreens Boots Alliance Inc", "COMP", "Net income attributable", "$821 million", "MONEY"], ["Walgreens Boots Alliance Inc", "COMP", "Impairment charge", "Guangzhou Pharmaceuticals", "COMP"], ["Walgreens Boots Alliance Inc", "COMP", "Earn", "$1.28 per share", "ECON_INDICATOR"], ["Walgreens Boots Alliance Inc", "COMP", "Lifted", "full-year adjusted profit forecast", "ECON_INDICATOR"], ["Walgreens Boots Alliance Inc", "COMP", "Analysts on average", "$5.56 per share", "ECON_INDICATOR"]], "published": "2018-01-04T14:23:00.000+02:00"}